4
Changes in Ownership
PepGen Inc. Filed Acc 0001127602-24-018155
SVP, Clinical Development sold 8,656 shares at an average $18.08 ($156,460)
- SVP, Clinical Development acquired 8,656 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mellion Michelle L · SVP, Clinical Development
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,245 | $10.21 | $73,971 | 7,245 | D |
| 2024-06-05 | Sale : show line 2 in the form 10b5-1 | −7,245 | $18.09 | $131,062 | 0 | D |
| 2024-06-06 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,411 | $10.21 | $14,406 | 1,411 | D |
| 2024-06-06 | Sale : show line 4 in the form 10b5-1 | −1,411 | $18.00 | $25,398 | 0 | D |
| Open-market sales · 8,656 sh · avg $18.08 · $156,460 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-05 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −7,245 | 92,755 | D |
| 2024-06-06 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,411 | 91,344 | D |
Loading xslF345X05/form4.xml…